Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan
Status:
Completed
Trial end date:
2014-11-04
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess PK, safety and tolerability of a single oral dose of
ASP3325 and to assess PD, PK and safety of repeated oral doses of ASP3325 administered t.i.d.
before or just after each meal